SC
Stralem & Co Portfolio holdings
AUM
$157M
1-Year Return
4.29%
This Quarter Return
-18.09%
1 Year Return
+4.29%
3 Year Return
+25.55%
5 Year Return
+55.64%
10 Year Return
–
AUM
$135M
AUM Growth
-$44.1M
(-25%)
Cap. Flow
-$8.89M
Cap. Flow
% of AUM
-6.6%
Top 10 Holdings %
Top 10 Hldgs %
35.48%
Holding
117
New
82
Increased
9
Reduced
25
Closed
1
Top Buys
| 1 |
Dow Inc
DOW
|
+$1M |
| 2 |
Aptiv
APTV
|
+$807K |
| 3 |
FedEx
FDX
|
+$746K |
| 4 |
Amazon
AMZN
|
+$606K |
| 5 |
RTN
Raytheon Company
RTN
|
+$492K |
Top Sells
| 1 |
Boeing
BA
|
+$4.34M |
| 2 |
Microsoft
MSFT
|
+$1.73M |
| 3 |
EOG Resources
EOG
|
+$1.7M |
| 4 |
Adobe
ADBE
|
+$767K |
| 5 |
American Electric Power
AEP
|
+$647K |
Sector Composition
| 1 | Healthcare | 25.63% |
| 2 | Technology | 19.14% |
| 3 | Financials | 10.56% |
| 4 | Communication Services | 9.97% |
| 5 | Utilities | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vanguard Value ETF
VTV
$145B
| $48K | 0.04% |
+535
| New | +$48K |
|
52
Apple
AAPL
$3.47T
| $39K | 0.03% |
+612
| New | +$39K |
|
53
iShares Russell Mid-Cap Growth ETF
IWP
$20.6B
| $36K | 0.03% |
+588
| New | +$36K |
|
54
Allogene Therapeutics
ALLO
$251M
| $32K | 0.02% |
+1,650
| New | +$32K |
|
55
Biogen
BIIB
$21.2B
| $32K | 0.02% |
+101
| New | +$32K |
|
|
TWTR
56
DELISTED
Twitter, Inc.
TWTR
| $31K | 0.02% |
+1,250
| New | +$31K |
|
57
iShares MSCI EAFE Small-Cap ETF
SCZ
$10.9B
| $24K | 0.02% |
+532
| New | +$24K |
|
58
Baidu
BIDU
$39.5B
| $23K | 0.02% |
+225
| New | +$23K |
|
59
Catalyst Pharmaceutical
CPRX
$2.44B
| $11K | 0.01% |
+2,900
| New | +$11K |
|
60
Bright Horizons
BFAM
$6.45B
| $10K | 0.01% |
+100
| New | +$10K |
|
61
T-Mobile US
TMUS
$272B
| $10K | 0.01% |
+117
| New | +$10K |
|
62
Bank of America
BAC
$375B
| $9K | 0.01% |
+436
| New | +$9K |
|
63
Intel
INTC
$112B
| $7K | 0.01% |
+129
| New | +$7K |
|
64
Wells Fargo
WFC
$261B
| $7K | 0.01% |
+246
| New | +$7K |
|
65
Cigna
CI
$80.8B
| $6K | ﹤0.01% |
+34
| New | +$6K |
|
66
Comcast
CMCSA
$122B
| $6K | ﹤0.01% |
+164
| New | +$6K |
|
67
Gilead Sciences
GILD
$142B
| $6K | ﹤0.01% |
+78
| New | +$6K |
|
68
Philip Morris
PM
$259B
| $6K | ﹤0.01% |
+78
| New | +$6K |
|
69
Under Armour Class C
UA
$2.04B
| $6K | ﹤0.01% |
+743
| New | +$6K |
|
70
McKesson
MCK
$88.5B
| $5K | ﹤0.01% |
+39
| New | +$5K |
|
71
PepsiCo
PEP
$197B
| $5K | ﹤0.01% |
+45
| New | +$5K |
|
72
AstraZeneca
AZN
$247B
| $5K | ﹤0.01% |
+112
| New | +$5K |
|
73
Everest Group
EG
$14.7B
| $5K | ﹤0.01% |
+27
| New | +$5K |
|
74
American International
AIG
$43.7B
| $4K | ﹤0.01% |
+153
| New | +$4K |
|
75
Charter Communications
CHTR
$36B
| $4K | ﹤0.01% |
+10
| New | +$4K |
|